Ascend Wellness Holdings (AAWH) Other Accumulated Expenses (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Other Accumulated Expenses of $9.0 million in Q1 2026, up 27.41% quarter-over-quarter from $7.1 million in Q4 2025, and up 73.1% on a YoY basis from $5.2 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 73.1% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $9.0 million (up 73.1% YoY), while the FY2025 annual figure was $7.1 million, up 39.72% from the prior year.
- Other Accumulated Expenses was $9.0 million for Q1 2026 at Ascend Wellness Holdings, up from $7.1 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $9.0 million in Q1 2026 to a low of $4.1 million in Q1 2022.
- Historically, Other Accumulated Expenses has averaged $5.9 million across 5 years, with a median of $5.5 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses retreated 29.4% in 2025, then surged 73.1% in 2026.
- A 5-year view of Other Accumulated Expenses shows it stood at $5.7 million in 2022, then rose by 18.41% to $6.8 million in 2023, then fell by 25.21% to $5.1 million in 2024, then surged by 39.72% to $7.1 million in 2025, then climbed by 27.41% to $9.0 million in 2026.
- The last three Other Accumulated Expenses figures came in at $9.0 million (Q1 2026), $7.1 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.01 Mn |
| Dec 31, 2025 | 7.07 Mn |
| Sep 30, 2025 | 5.33 Mn |
| Jun 30, 2025 | 5.03 Mn |
| Mar 31, 2025 | 5.20 Mn |
| Dec 31, 2024 | 5.06 Mn |
| Sep 30, 2024 | 6.62 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | 7.37 Mn |
| Dec 31, 2023 | 6.77 Mn |
| Sep 30, 2023 | 6.33 Mn |
| Jun 30, 2023 | 5.53 Mn |
| Mar 31, 2023 | 4.55 Mn |
| Dec 31, 2022 | 5.71 Mn |
| Sep 30, 2022 | 4.50 Mn |
| Jun 30, 2022 | 4.55 Mn |
| Mar 31, 2022 | 4.05 Mn |
| Dec 31, 2021 | 5.15 Mn |
| Sep 30, 2021 | 4.99 Mn |
| Jun 30, 2021 | 5.74 Mn |